Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.
Richard J Miron, Vittorio Moraschini, Masako Fujioka-Kobayashi...
https://pubmed.ncbi.nlm.nih.gov/33609186/Actively Recruiting
Led by Semmelweis University · Updated on 2026-04-28
36
Participants Needed
1
Research Sites
24 weeks
Total Duration
Researchers are evaluating the healing of intrabony periodontal defects using two approaches combined with Platelet Rich Fibrin PRF a minimally invasive surgical technique MIST and guided biofilm therapy GBT. This prospective, randomized controlled clinical study aims to compare the clinical and radiological outcomes of these treatments in patients with solitary deep intrabony periodontal defects. The main focus is to see if adding PRF improves healing and whether the surgical approach offers advantages compared to non-surgical therapy. The study includes three groups one receiving non-surgical guided biofilm therapy combined with PRF, another undergoing minimally invasive surgical treatment with PRF placed into the defect, and a control group treated only with guided biofilm therapy. The surgical group involves opening a flap to access the defect before applying PRF, while the non-surgical group applies PRF into cleaned defects without flap opening. The control group receives cleaning without PRF. Treatments are performed according to standardized protocols. Participants will be assessed at the start and six months after treatment. Clinical periodontal parameters, such as probing pocket depth, gingival recession, and clinical attachment level, will be measured. Healing will also be evaluated radiologically using standardized X-rays. The primary outcome is the change in clinical attachment level after six months. Safety, healing progress, and adherence to oral hygiene and follow-up procedures will be monitored throughout the study, which lasts at least six months after treatment.
CONDITIONS
Comparison of MIST With PRF and GBT With PRF in the Treatment of Intrabony Periodontal Defect. A Prospective RCT
P
Pál Nagy, DMD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Semmelweis University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment session
Participants receive one of the following treatments: non-surgical guided biofilm therapy with Platelet Rich Fibrin, minimally invasive surgical therapy with Platelet Rich Fibrin, or guided biofilm therapy alone to treat the intrabony periodontal defect.
1 treatment visit (in-person)
Duration - 6 months
Participants are monitored for healing and clinical outcomes including periodontal parameters and radiological evaluation at 6 months after treatment.
1 follow-up visit at 6 months (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Richard J Miron, Vittorio Moraschini, Masako Fujioka-Kobayashi...
https://pubmed.ncbi.nlm.nih.gov/33609186/Richard J Miron, Masako Fujioka-Kobayashi, Mark Bishara...
https://pubmed.ncbi.nlm.nih.gov/27672729/Pierpaolo Cortellini, Simone Cortellini, Daniele Bonaccini...
https://pubmed.ncbi.nlm.nih.gov/35415940/Gauresh Kumar Patel, Shivali S Gaekwad, Sheela Kumar Gujjari...
https://pubmed.ncbi.nlm.nih.gov/28820322/Semmelweis University
Lead Sponsor